Wells Fargo’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.29M | Buy |
|
|||||
|
2025
Q2 | $1.85M | Buy |
|
|||||
|
2025
Q1 | $2.86M | Buy |
|
|||||
|
2024
Q4 | $4.29M | Buy |
|
|||||
|
2024
Q3 | $5.41M | Buy |
|
|||||
|
2024
Q2 | $3.98M | Buy |
|
|||||
|
2024
Q1 | $5.45M | Buy |
|
|||||
|
2023
Q4 | $2.83M | Sell |
|
|||||
|
2023
Q3 | $2.43M | Buy |
|
|||||
|
2023
Q2 | $2.66M | Buy |
|
|||||
|
2023
Q1 | $1.51M | Buy |
|
|||||
|
2022
Q4 | $241K | Sell |
|
|||||
|
2022
Q3 | $558K | Buy |
|
|||||
|
2022
Q2 | $308K | Sell |
|
|||||
|
2022
Q1 | $868K | Sell |
|
|||||
|
2021
Q4 | $1.07M | Buy |
|
|||||
|
2021
Q3 | $1.22M | Sell |
|
|||||
|
2021
Q2 | $1.45M | Sell |
|
|||||
|
2021
Q1 | $1.92M | Sell |
|
|||||
|
2020
Q4 | $3.35M | Sell |
|
|||||
|
2020
Q3 | $3.85M | Sell |
|
|||||
|
2020
Q2 | $4.49M | Buy |
|
|||||
|
2020
Q1 | $3.22M | Sell |
|
|||||
|
2019
Q4 | $5.77M | Buy |
|
|||||
|
2019
Q3 | $3.63M | Buy |
|
|||||
|
2019
Q2 | $4.59M | Sell |
|
|||||
|
2019
Q1 | $3.56M | Buy |
|
|||||
|
2018
Q4 | $2.12M | Buy |
|
|||||
|
2018
Q3 | $1.78M | Buy |
|
|||||
|
2018
Q2 | $1.06M | Buy |
|
|||||
|
2018
Q1 | $926K | Buy |
|
|||||
|
2017
Q4 | $398K | Sell |
|
|||||
|
2017
Q3 | $801K | Buy |
|
|||||
|
2017
Q2 | $528K | Buy |
|
|||||
|
2017
Q1 | $374K | Buy |
|
|||||
|
2016
Q4 | $265K | Buy |
|
|||||
|
2016
Q3 | $158K | Hold |
|
|||||
|
2016
Q2 | $155K | Sell |
|
|||||
|
2016
Q1 | $112K | Buy |
|
|||||
|
2015
Q4 | $149K | Sell |
|
|||||
|
2015
Q3 | $1.16M | Buy |
|
|||||
|
2015
Q2 | $21K | Buy |
|